VolitionRx Limited
VNRX · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 54.2% | 65.1% | 28.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -673.9% | -1,363.9% | -2,058.4% | -2,824.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -857.4% | -1,545.2% | -2,201.3% | -3,022.8% |
| EPS Diluted | -0.05 | -0.061 | -0.056 | -0.066 |
| % Growth | 18.3% | -8.9% | 14.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |